Evidence map›Paper›PMID 42168500›Full record

ArticleScientific reports2026

Research on multi-stage deep learning based intelligent diagnosis of skin diseases and skin medicine diagnosis community construction concept.

Junzhang Chen, Fapeng Cai, Weizhe Ding, Dong Liang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Junzhang ChenYinshan Town Convenience Service Center, Neijiang, 641000, Sichuan, China.
Fapeng CaiNeijiang Educational Technology Equipment Guidance Center, Neijiang, 641000, Sichuan, China. cbill0106@gmail.com.
Weizhe DingNeijiang Big Data center, Neijiang, 641000, Sichuan, China.
Dong LiangNeijiang Food and Drug Inspection and Testing Center, Neijiang, 641000, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate diagnosis and assessment of the severity of skin diseases are essential for appropriate clinical treatment. This paper proposes a multi-stage intelligent diagnosis framework based on deep learning to assist dermatologists in decision-making in the early stage. It also puts forward a conceptual feasible model for developing an integrated self-service diagnosis and medication dispensing community in the future mature stage. The framework firstly adopts LeNet-5 convolutional neural network for preliminary classification of common skin diseases, and then performs secondary classification of disease severity and progression for selected representative conditions. Through manual annotation, clinical prior knowledge, including the predilectable location of the lesion, is incorporated into the framework to improve the reliability of the diagnosis. All images were preprocessed with grayscale conversion to reduce visual variability. Experimental results show that the performance of the proposed framework is stable and reliable, especially in the recognition tasks of disease severity and stage with obvious clinical manifestations. This hierarchical diagnostic strategy conforms to routine clinical workflows and holds potential as a tool for precise diagnosis and treatment planning in dermatology.

Indexed as

Deep LearningDiagnosis, Computer-AssistedSkin DiseasesConvolutional Neural NetworksHumansSeverity of Illness IndexClinical decision supportDeep learningDiagnosis-medication service communityDiagnosis of skin diseasesGrading of severity

Identifiers

PMID42168500
PMCPMC13442873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.